Establishing Tamoxifen-Resistant Breast Cancer Cell Lines
Corresponding Organization :
Other organizations : Fujian Medical University, Union Hospital, First Affiliated Hospital of Fujian Medical University
Variable analysis
- Concentration of 4-hydroxytamoxifen (starting at 0.5 μM, gradually increased up to 5 μM)
- Treatment with SP600125, etomoxir, and puromycin
- Growth of cells
- Cell lines: MCF7, T47D, and HEK293T
- Culture medium: DMEM with 10% fetal bovine serum and 1% penicillin–streptomycin
- Culture conditions: 37 °C, 5% CO2, humidified atmosphere
- Parental MCF7 and T47D cells cultured without tamoxifen
- Not explicitly mentioned
- Parental MCF7 and T47D cells cultured without tamoxifen
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!